CORE LABORATORIES N.V. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-10-16: Form 8-K; Period of report 2013-10-16; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2013-10-08: Form 8-K; Period of report 2013-10-08; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2013-07-17: Form 8-K; Period of report 2013-07-17; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2013-07-09: Form 8-K; Period of report 2013-07-09; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2013-10-16 | 8-K | 2013-10-16 | 2.02 Results of Operations and Financial Condition | 2.02 On October 16, 2013, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2013 and year-to-date as of September 30, 2013. | clb-2013q3_earningsrelease.htm |
| 2013-10-08 | 8-K | 2013-10-08 | 7.01 Regulation FD Disclosure | 7.01 On October 8, 2013, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.32 per share of common stock for shareholders of record on October 18, 2013 and payable November 20, 2013. | clb-8k_dividend4q2013.htm |
| 2013-07-17 | 8-K | 2013-07-17 | 2.02 Results of Operations and Financial Condition | 2.02 On July 17, 2013, Core Laboratories N.V. issued a press release announcing its financial results for the second quarter of 2013 and year-to-date as of June 30, 2013. | clb-2013q2_earningsrelease.htm |
| 2013-07-09 | 8-K | 2013-07-09 | 7.01 Regulation FD Disclosure | 7.01 On July 9, 2013, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.32 per share of common stock for shareholders of record on July 19, 2013 and payable August 19, 2013. | clb-8k_dividend3q2013.htm |
| 2013-05-16 | 8-K | 2013-05-16 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Core Laboratories N.V. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”) on May 16, 2013. | annualmeetingofshareholder.htm |
| 2013-04-17 | 8-K | 2013-04-17 | 2.02 Results of Operations and Financial Condition | 2.02 On April 17, 2013, Core Laboratories N.V. issued a press release announcing its financial results for the first quarter of 2013. | clb-2013q1_earningsrelease.htm |
| 2013-04-15 | 8-K | 2013-04-15 | 7.01 Regulation FD Disclosure | 7.01 On April 15, 2013, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.32 per share of common stock for shareholders of record on April 26, 2013 and payable May 24, 2013. | clb-8k_dividend2q2013.htm |
| 2013-01-30 | 8-K | 2013-01-30 | 2.02 Results of Operations and Financial Condition | 2.02 On January 30, 2013, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2012 and full year ended December 31, 2012. | clb-2012q4_earningsrelease.htm |
| 2013-01-11 | 8-K | 2013-01-11 | 7.01 Regulation FD Disclosure | 7.01 On January 11, 2013, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.32 per share of common stock for shareholders of record on January 22, 2013 and payable February 22, 2013. | clb-8k_dividend1q2013.htm |
| 2013-01-02 | 8-K | 2012-12-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 2, 2011, the Supervisory Board of Directors (the “Board”) of Core Laboratories N.V. approved a Board Succession Plan. | a2012directorresignation.htm |